REFRACTORY PLASMA CELL MYELOMA
Clinical trials for REFRACTORY PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for REFRACTORY PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat myeloma
Disease control Recruiting nowThis early-phase study tests a new type of cell therapy for people with multiple myeloma that has returned or stopped responding to standard treatments. Participants receive chemotherapy followed by an infusion of their own immune cells that have been modified in a lab to recogni…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 17, 2026 17:02 UTC
-
New hope for tough myeloma: Triple-Drug combo trial launches
Disease control Recruiting nowThis study tests whether adding leflunomide to the standard drugs pomalidomide and dexamethasone can better control multiple myeloma that has come back or is resistant to treatment. About 29 adults with this type of blood cancer will receive the three-drug combination. The goal i…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Engineered virus targets Hard-to-Treat blood cancers in new trial
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New radiation 'Smart Bomb' targets Hard-to-Treat myeloma
Disease control Recruiting nowThis early-stage trial tests a new treatment for multiple myeloma that has come back or stopped responding to standard therapies. The treatment combines a cancer-targeting antibody (daratumumab) with a radioactive payload to deliver radiation directly to cancer cells. The study a…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Simple lifestyle changes and a common heart drug may improve quality of life for myeloma patients
Symptom relief Recruiting nowThis study looks at whether non-chemo approaches like physical activity, intermittent fasting, or adding a beta-blocker (propranolol) can improve immune function and quality of life in people with multiple myeloma or related blood disorders. Researchers will measure changes in im…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 17, 2026 12:08 UTC